The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Larger Will The Antimicrobial Susceptibility Testing Market Become By 2030 Compared To 2026?
The antimicrobial susceptibility testing market has shown robust expansion in recent years. Its value is anticipated to rise from $4.65 billion in 2025 to $4.93 billion in 2026, progressing at a compound annual growth rate (CAGR) of 6.0%. This growth observed in the past can be ascribed to an increasing prevalence of infectious diseases, growing recognition of antimicrobial resistance, the development of clinical microbiology laboratories, higher volumes of hospital diagnostic testing, and the availability of standardized AST protocols.
The antimicrobial susceptibility testing market is anticipated to experience significant expansion over the coming years. This market is projected to reach $6.01 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.1%. The projected growth during this period stems from factors such as increased investments in rapid diagnostic technologies, the rising acceptance of AI-assisted laboratory analysis, the expansion of antimicrobial resistance surveillance programs, a growing need for point-of-care AST solutions, and an intensified focus on precision antimicrobial therapy. Key trends expected during the forecast period encompass a greater adoption of automated AST systems, an escalating demand for rapid diagnostic testing, the increasing integration of molecular and phenotypic methods, an expansion of laboratory automation solutions, and a heightened emphasis on antimicrobial resistance monitoring.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4026&type=smp
What Market Drivers Are Helping Shape The Antimicrobial Susceptibility Testing Market Expansion?
The rising global occurrence of infectious diseases has contributed to the expansion of the antimicrobial susceptibility testing market. These illnesses are caused by organisms like bacteria, viruses, fungi, and parasites. Diseases stemming from bacteria include bacterial pneumonia and tuberculosis, while viral diseases encompass smallpox and AIDS, among others. For instance, in March 2024, data from the Centers for Disease Control and Prevention, a US-based national public health agency, indicated that in 2023, among 9,573 TB cases where birth origin was known, 7,259 (76%) occurred in non-U.S.–born persons. This represented an 18% increase compared with the 6,177 such cases reported in 2022. Consequently, the increasing incidence of infectious diseases is driving the growth of the antimicrobial susceptibility testing market.
What Are The Core Segment Classifications In The Antimicrobial Susceptibility Testing Market?
The antimicrobial susceptibility testing market covered in this report is segmented –
1) By Testing Type: Antibacterial Testing, Antifungal Testing, Antiparasitic Testing, Other Testing Types
2) By Product: Manual Antimicrobial Susceptibility Testing Products, Automated Laboratory Instruments, Consumables
3) By Application: Diagnostics, Drug Discovery and Development, Epidemiology, Other Applications
4) By End User: Hospitals And Diagnostic Centers, Pharmaceutical And Biotechnology Companies, Research And Academic Institutes, Clinical Research Organizations (CROs)
Subsegments:
1) By Antibacterial Testing: Disk Diffusion Method, Broth Dilution Method, E-Test Method, Automated Systems
2) By Antifungal Testing: Broth Dilution Method, Agar Disk Diffusion Method, E-Test Method, Colorimetric Methods
3) By Antiparasitic Testing: In vitro Susceptibility Testing, Microscopic Examination, Molecular Methods
4) By Other Testing Types: Mycobacterial Susceptibility Testing, Biofilm Susceptibility Testing, Combination Antimicrobial Testing
Which Trends Are Contributing To Changes In The Antimicrobial Susceptibility Testing Market?
Leading companies within the antimicrobial susceptibility testing market are creating advanced solutions, including the groundbreaking First POC Testing System. This First POC Testing System identifies the existence of bacteria and evaluates how well antimicrobials work by analyzing urine samples from individuals suspected of having urinary tract infections (UTIs). This represents a major advancement in AST technologies, facilitating quicker commencement of specific antimicrobial treatment for infected patients. As an example, in June 2023, Sysmex Corporation, a Japanese manufacturer of reagents and clinical testing equipment, encompassing hematologic and immune tests, introduced a new system designed for quick antimicrobial susceptibility detection. Utilizing its exclusive and proprietary microfluidic technology, the system provides antimicrobial susceptibility testing (AST) outcomes in as brief as 30 minutes from the measurement’s beginning, which is a considerable decrease from the multiple days traditionally needed for conventional AST.
Which Companies Form The Competitive Landscape Of The Antimicrobial Susceptibility Testing Market?
Major companies operating in the antimicrobial susceptibility testing market are BioMérieux SA, Becton Dickinson and Company, Thermo Fisher Scientific Inc., Danaher Corporation, Bio-Rad Laboratories Inc., Accelerate Diagnostics Inc., Alifax Holding S.p.A., Synbiosis Ltd., Mast Group Ltd., ELITechGroup, Genefluidics Inc., QuantaMatrix Inc., Bruker Corporation, Eurofins Scientific SE, Liofilchem s.r.l., Hardy Diagnostics, Bioanalyse GmbH, Lab M Limited, Microbiologics Inc., Quidel Corporation, R-Biopharm AG, SSI Diagnostica A/S
Access The Complete Antimicrobial Susceptibility Testing Market Report:
Which Geographic Region Represents The Largest Antimicrobial Susceptibility Testing Market Share?
North America was the largest region in the antimicrobial susceptibility testing market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the antimicrobial susceptibility testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Antimicrobial Susceptibility Testing Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=4026&type=smp
Browse Through More Reports Similar to the Global Antimicrobial Susceptibility Testing Market 2026, By The Business Research Company
Antimicrobial Medical Device Coatings Global Market Report 2026
Multidrug Resistant Bacteria Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/multidrug-resistant-bacteria-global-market-report
Genotyping Assay Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model